Anthropic changes usage policy to ban model abuse and election interference

Anthropic’s updated usage policy explicitly prohibits users from repeatedly abusing Claude in extreme cases, though ordinary frustration and criticism are still allowed. The new rules also address election interference, deceptive campaigns, weapons sof…

Anthropic is giving startups a free year of Claude Team and $1,000 in credits

“We created this program because we believe the benefits of AI will reach most people through the companies that build on top of models, rather than through the models alone.”

Sean Parker is rebuilding Stability AI around music

Sean Parker, who once taught the music industry what asking for forgiveness looks like, is now back with the labels’ blessing and money.

Pope Leo XIV is not a fan of AI-generated art

“There is an ontological difference, even before an aesthetic one, between art and what a machine can generate through statistical calculation based on millions of images created by others,” the pope wrote. “Algorithms lack the spark of humanity.”

Musk’s AI chatbot Grok reportedly encouraged Trump to capture Venezuela’s president

President Trump reportedly asked for Grok’s opinion before invading Venezuela and capturing Nicolás Maduro.

AI voice startup ElevenLabs doubles valuation to $22B

The $300 million employee tender was co-led by Wellington and T. Rowe Price.

Ahead of US IPO, British AI neocloud Nscale secures $3.36B in convertible financing

The funding, which comes from Third Point, Nvidia, and others, will fuel the company’s massive AI data center buildout.

North Korean hackers suspected in $351M crypto theft, the largest so far this year

The $351 million theft from crypto exchange Bitget is the latest in a string of high-profile hacks targeting the crypto sector.

VC firm Bessemer now has another $5.75B to invest in (what else?) AI

The VC firm says that AI-native companies are growing faster than any technology, ever.

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.